— Know what they know.
Not Investment Advice

RGIN OTC

Regenicin, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -66.7% 1Y: +0.0% 3Y: -97.1% 5Y: -99.2%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 44 · $15348 mcap · 153M float · 0.060% daily turnover · Short 5% of daily vol

Balance Sheet Trends

Total Assets
$15K +236.2% ▲
5Y CAGR: -29.3%
Total Liabilities
$6M +8.6% ▲
5Y CAGR: +17.3%
Shareholders Equity
-$6M -8.4% ▼
Cash & Investments
$15K +236.2% ▲
5Y CAGR: -10.6%
Total Debt
$643K +6.6% ▲
5Y CAGR: +29.7%
Net Debt
$628K +4.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$3K$815$1K$2K$15K
Short-Term Investments$8K$4K$3K$3K$925
Cash & ST Investments$11K$5K$4K$5K$15K
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$56K$5K$4K$5K$15K
Property, Plant & Equip.$0$0$0$0$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0-$3K$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$0$0-$3K$0$0
Total Assets$56K$5K$4K$5K$15K
— Liabilities —
Accounts Payable$68K$138K$89K$94K$103K
Short-Term Debt$360K$455K$578K$603K$643K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$0$0$0
Total Current Liabilities$3M$4M$4M$5M$6M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$0$0
Total Liabilities$3M$4M$4M$5M$6M
— Equity —
Common Stock$158K$158K$158K$158K$158K
Retained Earnings-$13M-$14M-$15M-$16M-$16M
Accumulated OCI$950-$0$0$0$0
Total Stockholders Equity-$3M-$4M-$4M-$5M-$6M
Total Liabilities & Equity$56K$5K$4K$5K$15K
— Key Metrics —
Total Debt$213K$455K$578K$603K$643K
Net Debt$210K$454K$577K$601K$628K
Total Investments$8K$4K$3K$3K$925

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms